Discovery Labs ($DSCO): No Hesitation, Discovery Is Raising Dollars in the wake of Good FDA News
Thursday, March 15, 2012 at 4:08PM
DDE Editor in Specialty Pharma, dsco, lazard

 

Discovery Labs ($DSCO) announces proposed public offering of undetermined amounce of common stock through Lazard.

Lazard Capital Markets LLC is acting as the sole book-running manager for the offering, Stifel Nicolaus Weisel is acting as co-lead manager, and ROTH Capital Partners, LLC is acting as co-manager , see ournote from earlier in the week regarding Surfaxin, 4th times a charm.

Article originally appeared on Daily Dose Equities - Wall Street Analysis for Biomedical Research (http://dailydoseequities.filmannex.com/).
See website for complete article licensing information.